| Financial Year |
March 31 2023 |
| Monetary Funds |
342,971,014.97 |
| Held-for-trading Financial Assets |
61,572,132.55 |
| Notes Receivable |
90,332,518.96 |
| Accounts Receivable |
716,478,627.22 |
| Advances to Suppliers |
23,930,276.45 |
| Other Receivables |
4,884,214.56 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
424,527,376.08 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,215,305.86 |
| Total Current Assets |
1,673,032,153.60 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
30,009,787.53 |
| Under-construction Projects |
2,174,999.96 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
283,787,502.56 |
| R&D expenses |
-- |
| Goodwill |
98,466,394.84 |
| Long-Term Deferred and Prepaid Expenses |
4,559,068.34 |
| Deferred Income Tax Assets |
13,040,111.16 |
| Other Non-Current Assets |
24,249,270.38 |
| Sub-Total of Non-Current Assets |
513,536,427.87 |
| Total Assets |
2,186,568,581.47 |
| Short-Term Loans |
708,775,872.58 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
89,173,461.21 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,443,490.64 |
| Taxes Payable |
13,782,457.05 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
136,634,901.73 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,025,650.70 |
| Other Current Liabilities |
327,843.85 |
| Sub-Total of Current Liabilities |
972,108,465.77 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
48,407,991.10 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
53,311,037.21 |
| Total Liabilities |
1,025,419,502.98 |
| Paid-In Capital(Or Share Stock) |
80,000,000.00 |
| Capital Surplus |
522,267,610.63 |
| Surplus Reserve |
19,432,830.81 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
361,921,108.04 |
| Minority Stockholder's Interest |
171,814,655.17 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
989,334,423.32 |
| Owner's Equity（Stockholder's Equity） |
1,161,149,078.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,186,568,581.47 |
